SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015086
Filing Date
2021-11-08
Accepted
2021-11-08 17:19:01
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20210930x10q.htm   iXBRL 10-Q 2310745
2 EX-31.1 xncr-20210930xex31d1.htm EX-31.1 17199
3 EX-31.2 xncr-20210930xex31d2.htm EX-31.2 17133
4 EX-32.1 xncr-20210930xex32d1.htm EX-32.1 10062
  Complete submission text file 0001558370-21-015086.txt   9603106

Data Files

Seq Description Document Type Size
5 EX-101.SCH xncr-20210930.xsd EX-101.SCH 47478
6 EX-101.CAL xncr-20210930_cal.xml EX-101.CAL 57432
7 EX-101.DEF xncr-20210930_def.xml EX-101.DEF 237131
8 EX-101.LAB xncr-20210930_lab.xml EX-101.LAB 481148
9 EX-101.PRE xncr-20210930_pre.xml EX-101.PRE 383864
10 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20210930x10q_htm.xml XML 2038244
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 211388947
SIC: 2834 Pharmaceutical Preparations